These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 38457782)
1. Conjugation to Native and Nonnative Triscatecholate Siderophores Enhances Delivery and Antibacterial Activity of a β-Lactam to Gram-Negative Bacterial Pathogens. Motz RN; Guo C; Sargun A; Walker GT; Sassone-Corsi M; Raffatellu M; Nolan EM J Am Chem Soc; 2024 Mar; 146(11):7708-7722. PubMed ID: 38457782 [TBL] [Abstract][Full Text] [Related]
2. Exploring the Antibacterial Activity and Cellular Fates of Enterobactin-Drug Conjugates That Target Gram-Negative Bacterial Pathogens. Guo C; Nolan EM Acc Chem Res; 2024 Apr; 57(7):1046-1056. PubMed ID: 38483177 [TBL] [Abstract][Full Text] [Related]
3. Enterobactin-mediated delivery of β-lactam antibiotics enhances antibacterial activity against pathogenic Escherichia coli. Zheng T; Nolan EM J Am Chem Soc; 2014 Jul; 136(27):9677-91. PubMed ID: 24927110 [TBL] [Abstract][Full Text] [Related]
4. Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Chairatana P; Zheng T; Nolan EM Chem Sci; 2015 Aug; 6(8):4458-4471. PubMed ID: 28717471 [TBL] [Abstract][Full Text] [Related]
5. Investigation of Siderophore-Platinum(IV) Conjugates Reveals Differing Antibacterial Activity and DNA Damage Depending on the Platinum Cargo. Guo C; Wang KA; Nolan EM ACS Infect Dis; 2024 Apr; 10(4):1250-1266. PubMed ID: 38436588 [TBL] [Abstract][Full Text] [Related]
6. Esterase-Catalyzed Siderophore Hydrolysis Activates an Enterobactin-Ciprofloxacin Conjugate and Confers Targeted Antibacterial Activity. Neumann W; Sassone-Corsi M; Raffatellu M; Nolan EM J Am Chem Soc; 2018 Apr; 140(15):5193-5201. PubMed ID: 29578687 [TBL] [Abstract][Full Text] [Related]
7. Conjugation to Enterobactin and Salmochelin S4 Enhances the Antimicrobial Activity and Selectivity of β-Lactam Antibiotics against Nontyphoidal Sargun A; Sassone-Corsi M; Zheng T; Raffatellu M; Nolan EM ACS Infect Dis; 2021 May; 7(5):1248-1259. PubMed ID: 33691061 [TBL] [Abstract][Full Text] [Related]
8. Enterobactin-specific antibodies inhibit in vitro growth of different gram-negative bacterial pathogens. Wang H; Zeng X; Lin J Vaccine; 2020 Nov; 38(49):7764-7773. PubMed ID: 33164800 [TBL] [Abstract][Full Text] [Related]
9. The bacterial siderophore enterobactin confers survival advantage to Saha P; Xiao X; Yeoh BS; Chen Q; Katkere B; Kirimanjeswara GS; Vijay-Kumar M Gut Microbes; 2019; 10(3):412-423. PubMed ID: 30449241 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics. Cherian PT; Deshpande A; Cheramie MN; Bruhn DF; Hurdle JG; Lee RE J Antibiot (Tokyo); 2017 Jan; 70(1):65-72. PubMed ID: 27189120 [TBL] [Abstract][Full Text] [Related]
11. Heavy-Metal Trojan Horse: Enterobactin-Directed Delivery of Platinum(IV) Prodrugs to Guo C; Nolan EM J Am Chem Soc; 2022 Jul; 144(28):12756-12768. PubMed ID: 35803281 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a reducible disulfide linker for siderophore-mediated delivery of antibiotics. Neumann W; Nolan EM J Biol Inorg Chem; 2018 Oct; 23(7):1025-1036. PubMed ID: 29968176 [TBL] [Abstract][Full Text] [Related]
13. The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics. Page MGP Clin Infect Dis; 2019 Nov; 69(Suppl 7):S529-S537. PubMed ID: 31724044 [TBL] [Abstract][Full Text] [Related]
14. Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam. McPherson CJ; Aschenbrenner LM; Lacey BM; Fahnoe KC; Lemmon MM; Finegan SM; Tadakamalla B; O'Donnell JP; Mueller JP; Tomaras AP Antimicrob Agents Chemother; 2012 Dec; 56(12):6334-42. PubMed ID: 23027195 [TBL] [Abstract][Full Text] [Related]
15. Hijacking of the Enterobactin Pathway by a Synthetic Catechol Vector Designed for Oxazolidinone Antibiotic Delivery in Moynié L; Hoegy F; Milenkovic S; Munier M; Paulen A; Gasser V; Faucon AL; Zill N; Naismith JH; Ceccarelli M; Schalk IJ; Mislin GLA ACS Infect Dis; 2022 Sep; 8(9):1894-1904. PubMed ID: 35881068 [TBL] [Abstract][Full Text] [Related]
16. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199 [TBL] [Abstract][Full Text] [Related]
17. Uptake Mechanisms and Regulatory Responses to MECAM- and DOTAM-Based Artificial Siderophores and Their Antibiotic Conjugates in Fritsch S; Gasser V; Peukert C; Pinkert L; Kuhn L; Perraud Q; Normant V; Brönstrup M; Schalk IJ ACS Infect Dis; 2022 Jun; 8(6):1134-1146. PubMed ID: 35500104 [TBL] [Abstract][Full Text] [Related]
18. Fluorescence High-Throughput Screening for Inhibitors of TonB Action. Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720 [TBL] [Abstract][Full Text] [Related]
19. Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria. Brochu A; Brochu N; Nicas TI; Parr TR; Minnick AA; Dolence EK; McKee JA; Miller MJ; Lavoie MC; Malouin F Antimicrob Agents Chemother; 1992 Oct; 36(10):2166-75. PubMed ID: 1444296 [TBL] [Abstract][Full Text] [Related]
20. Enterobactin- and salmochelin-β-lactam conjugates induce cell morphologies consistent with inhibition of penicillin-binding proteins in uropathogenic Sargun A; Johnstone TC; Zhi H; Raffatellu M; Nolan EM Chem Sci; 2021 Jan; 12(11):4041-4056. PubMed ID: 34163675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]